Search research articles
Contact Us
Filters
Showing results (191-200 of 204) with videos related to
Page
of 21
Sort By:
The Journal of Invasive Cardiology
|
December 8, 2009
Preprocedural inflammation does not affect neointimal hyperplasia following everolimus-eluting stent implantation
Daisaku Nakatani, Junya Ako, Masao Yamasaki, et al.
The Journal of Invasive Cardiology
|
September 8, 2012
Mid-term results of everolimus-eluting stent in a Japanese population compared with a US randomized cohort: SPIRIT III Japan Registry with harmonization by doing
Shigeru Saito, Shigeru Nakamura, Kenshi Fujii, et al.
Journal of the American College of Cardiology
|
December 19, 2006
Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial
David E Kandzari, Martin B Leon, Jeffrey J Popma, et al.
Circulation. Cardiovascular Interventions
|
November 11, 2010
Six-month results of the NEVO Res-Elution I (NEVO RES-I) trial: a randomized, multicenter comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Liberté paclitaxel-eluting stent in de novo native coronary artery lesions
John A Ormiston, Alexandre Abizaid, John Spertus, et al.
Journal of Cardiology
|
April 24, 2021
Intravascular ultrasound predictors of long-term outcomes following ABSORB bioresorbable scaffold implantation: A pooled analysis of the ABSORB III and ABSORB Japan trials
Takeshi Nishi, Kozo Okada, Hideki Kitahara, et al.
The American Journal of Cardiology
|
November 28, 2006
Comparison of the efficacy of direct coronary stenting with sirolimus-eluting stents versus stenting with predilation by intravascular ultrasound imaging (from the DIRECT trial)
Atsushi Hirohata, Yoshihiro Morino, Junya Ako, et al.
Circulation. Cardiovascular Interventions
|
December 25, 2009
A randomized controlled trial of angiography versus intravascular ultrasound-directed bare-metal coronary stent placement (the AVID Trial)
Robert J Russo, Patricia D Silva, Paul S Teirstein, et al.
Journal of the American College of Cardiology
|
April 19, 2008
A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study
Mitchell W Krucoff, Dean J Kereiakes, John L Petersen, et al.
International Journal of Cardiology
|
June 11, 2011
A randomized, controlled, multi-center trial comparing the safety and efficacy of zotarolimus-eluting and paclitaxel-eluting stents in de novo lesions in coronary arteries: final results of the ZoMaxx II trial
William A Gray, Alan C Yeung, Donald E Cutlip, et al.
JACC. Cardiovascular Interventions
|
January 11, 2020
Randomized Comparison Between Everolimus-Eluting Bioresorbable Scaffold and Metallic Stent: Multimodality Imaging Through 3 Years
Yoshinobu Onuma, Yasuhiro Honda, Taku Asano, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 204) with videos related to
Sort By:
Page
of 21
The Journal of Invasive Cardiology
|
December 8, 2009
Preprocedural inflammation does not affect neointimal hyperplasia following everolimus-eluting stent implantation
Daisaku Nakatani, Junya Ako, Masao Yamasaki, et al.
The Journal of Invasive Cardiology
|
September 8, 2012
Mid-term results of everolimus-eluting stent in a Japanese population compared with a US randomized cohort: SPIRIT III Japan Registry with harmonization by doing
Shigeru Saito, Shigeru Nakamura, Kenshi Fujii, et al.
Journal of the American College of Cardiology
|
December 19, 2006
Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial
David E Kandzari, Martin B Leon, Jeffrey J Popma, et al.
Circulation. Cardiovascular Interventions
|
November 11, 2010
Six-month results of the NEVO Res-Elution I (NEVO RES-I) trial: a randomized, multicenter comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Liberté paclitaxel-eluting stent in de novo native coronary artery lesions
John A Ormiston, Alexandre Abizaid, John Spertus, et al.
Journal of Cardiology
|
April 24, 2021
Intravascular ultrasound predictors of long-term outcomes following ABSORB bioresorbable scaffold implantation: A pooled analysis of the ABSORB III and ABSORB Japan trials
Takeshi Nishi, Kozo Okada, Hideki Kitahara, et al.
The American Journal of Cardiology
|
November 28, 2006
Comparison of the efficacy of direct coronary stenting with sirolimus-eluting stents versus stenting with predilation by intravascular ultrasound imaging (from the DIRECT trial)
Atsushi Hirohata, Yoshihiro Morino, Junya Ako, et al.
Circulation. Cardiovascular Interventions
|
December 25, 2009
A randomized controlled trial of angiography versus intravascular ultrasound-directed bare-metal coronary stent placement (the AVID Trial)
Robert J Russo, Patricia D Silva, Paul S Teirstein, et al.
Journal of the American College of Cardiology
|
April 19, 2008
A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study
Mitchell W Krucoff, Dean J Kereiakes, John L Petersen, et al.
International Journal of Cardiology
|
June 11, 2011
A randomized, controlled, multi-center trial comparing the safety and efficacy of zotarolimus-eluting and paclitaxel-eluting stents in de novo lesions in coronary arteries: final results of the ZoMaxx II trial
William A Gray, Alan C Yeung, Donald E Cutlip, et al.
JACC. Cardiovascular Interventions
|
January 11, 2020
Randomized Comparison Between Everolimus-Eluting Bioresorbable Scaffold and Metallic Stent: Multimodality Imaging Through 3 Years
Yoshinobu Onuma, Yasuhiro Honda, Taku Asano, et al.
Page
of 21